Quarterly report [Sections 13 or 15(d)]

Collaborations, Licensing Agreements and Other Agreements - Additional Information (Details)

v3.25.1
Collaborations, Licensing Agreements and Other Agreements - Additional Information (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2024
Mar. 31, 2023
May 31, 2020
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2025
Jan. 31, 2024
Dec. 31, 2023
Aug. 31, 2023
May 31, 2023
Oct. 07, 2022
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Research and development expense       $ 29,018 $ 21,954            
Upfront payment               $ 1,100      
License Agreement                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Obligation to be paid       $ 2,000              
Payment term       3 years              
License maintenance fee     $ 33 $ 10              
Total milestone payments       21,000              
Amounts due to agreement       0              
Sponsored Research Agreements                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Obligation to be paid       12,560              
Master Translational Research Services Agreement                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Research and development expense       1,042 713            
Remaining research and development expense to be incurred       643              
Master Translational Research Services Agreement | Subsequent Event                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Research and development expense           $ 2,250          
Oxford Biomedica                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Obligation to be paid                 $ 5,000    
Research and development expense $ 11,000     11,000              
Upfront payment                   $ 500  
Nanjing IASO Biotherapeutics Co., Ltd.                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Total milestone payments   $ 1,000     $ 1,500            
Upfront payment       162,000             $ 2,500
Autolus Holdings                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Upfront payment   $ 1,200         $ 100        
Autolus Holdings | Maximum                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Total milestone payments       15,000              
Autolus Holdings | Maximum | License and Service                      
Collaborations, Licensing Agreements And Other Agreements [Line Items]                      
Total milestone payments       $ 12,000